LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged health care · clear

Pharma & ANDA

How Do Patents Affect The Healthcare Industry?

Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound like a good industry to be in, but keep in mind that the costs of developing a new drug range from $300 million up to…

May 1, 2022·Pharma & ANDA·2 min read
Pharma & ANDA

Generic drug lawsuits -- good business practice or unfair monopoly?

Janssen Pharmaceuticals, Inc. , manufacturers of the Ortho Tri-Cyclen birth control drug, are filing an injunction against Glenmark Generics, Ltd. , an Indian-based generic drug manufacturer that manufactures and sells numerous generic products within the…

August 23, 2012·Pharma & ANDA·5 min read
Supreme Court

Biotechs can patent your body and profit, without your permission

When we think of patent law, we often think of technology, engineering, and intellectual property. Rarely do we think of living organisms. In 1980, however, the Supreme Court ruled that man-made organisms could be patented by the scientists who created…

October 25, 2011·Supreme Court·2 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data